Cwm, LLC Surmodics Inc Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Cwm, LLC holds 1,047 shares of SRDX stock, worth $28,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,047

Previous 633 65.4%

Holding current value

$28,446

Previous $19,000 63.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$29.0 - $38.0 $12,006 - $15,732	414 Added 65.4%	1,047 $31,000
Q2 2025 Jul 25, 2025	BUY	$26.76 - $31.1 $7,546 - $8,770	282 Added 80.34%	633 $19,000
Q1 2025 May 01, 2025	SELL	$26.71 - $39.71 $3,979 - $5,916	-149 Reduced 29.8%	351 $11,000
Q4 2024 Feb 04, 2025	SELL	$37.5 - $40.13 $150 - $160	-4 Reduced 0.79%	500 $20,000
Q3 2024 Oct 08, 2024	SELL	$38.47 - $42.24 $38 - $42	-1 Reduced 0.2%	504 $20,000
Q2 2024 Jul 09, 2024	BUY	$25.39 - $42.1 $50 - $84	2 Added 0.4%	505 $21,000
Q1 2024 Apr 05, 2024	BUY	$27.44 - $35.56 $3,183 - $4,124	116 Added 29.97%	503 $15,000
Q4 2023 Feb 01, 2024	BUY	$28.47 - $38.49 $882 - $1,193	31 Added 8.71%	387 $14,000
Q2 2023 Aug 03, 2023	SELL	$17.67 - $31.31 $194 - $344	-11 Reduced 3.0%	356 $11,000
Q1 2023 Apr 28, 2023	BUY	$17.13 - $38.52 $5,635 - $12,673	329 Added 865.79%	367 $8,000
Q4 2022 Feb 01, 2023	BUY	$29.44 - $37.31 $412 - $522	14 Added 58.33%	38 $1,000
Q3 2022 Oct 27, 2022	SELL	$28.84 - $38.92 $317 - $428	-11 Reduced 31.43%	24 $1,000
Q2 2022 Jul 28, 2022	BUY	$33.25 - $45.11 $1,163 - $1,578	35 New	35 $1,000
Q1 2022 Apr 21, 2022	SELL	$40.68 - $49.72 $2,237 - $2,734	-55 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$43.21 - $57.6 $2,376 - $3,168	55 New	55 $3,000

Others Institutions Holding SRDX

# of Institutions

147

Shares Held

12.4M

Call Options Held

108K

Put Options Held

212K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $381M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account